相关实验视频

Updated: May 30, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

在协同药物发现中积极学习的指南

Shuhui Wang^1,2, Alexandre Allauzen^1,2, Philippe Nghe¹

¹Laboratoire de Biophysique et Evolution, UMR CNRS-ESPCI 8231 Chimie Biologie Innovation, PSL University, Paris, France.

Scientific reports

|January 28, 2025

概括

积极学习通过优先考虑实验测试来增强人工智能 (AI) 对协同药物组合的预测. 这种方法显著提高了药物发现效率,在10%的搜索空间内识别了60%的协同效应对.

科学领域:

计算机化药物发现.
药理学中的人工智能
机器学习用于药物协同作用.

背景情况:

协同药物组合查对于药物发现至关重要,但由于广而复杂的搜索空间,它面临着挑战.
目前用于预测药物协同作用的人工智能 (AI) 模型受到查数据中协同作用药物对的稀有性限制.
积极学习通过将实验验证整合到人工智能模型的学习周期中,提供了一个潜在的解决方案.

研究的目的:

在药物协同作用预测的背景下,研究积极学习的关键组成部分和最佳实施策略.
评估不同特征 (如分子编码和细胞环境) 对预测性能的影响.
量化积极学习在发现协同作用药物组合中的效率增长.

主要方法:

探索积极学习策略,以协同识别药物对.
评估分子编码和细胞环境特征对预测准确性的影响.
分析不同批量大小和勘探开发策略的积极学习绩效.

主要成果:

分子编码对预测性能的影响很小,而细胞环境的功能显著改善了协同预测.
积极学习成功地识别了60%的协同药物对,同时只探索了10%的组合化学空间.
较小的批量规模进一步提高了协同效应收益率,探索开发策略的动态调整提供了额外的性能提升.

结论:

积极学习是加速发现协同作用药物组合的高效策略.
整合细胞环境特征对于改进人工智能驱动的协同预测模型至关重要.
在积极学习中优化批量大小和探索策略可以显著提高药物发现管道的效率.

更多相关视频

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Agonism and Antagonism: Quantification

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

Principles of Drug Action

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...